Molecular Partners AG
SIX:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
SIX:MOLN
Watchlist
Price: 4.815 CHF 0.31% Market Closed
Market Cap: 177.5m CHF
Have any thoughts about
Molecular Partners AG?
Write Note

Wall Street
Price Targets

MOLN Price Targets Summary
Molecular Partners AG

Wall Street analysts forecast MOLN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MOLN is 11.22 CHF with a low forecast of 7.07 CHF and a high forecast of 15.75 CHF.

Lowest
Price Target
7.07 CHF
47% Upside
Average
Price Target
11.22 CHF
133% Upside
Highest
Price Target
15.75 CHF
227% Upside
Molecular Partners AG Competitors:
Price Targets
REGN
Regeneron Pharmaceuticals Inc
48% Upside
1952
Everest Medicines Ltd
21% Downside
AKBA
Akebia Therapeutics Inc
198% Upside
KOD
Kodiak Sciences Inc
27% Downside
T5O
CytoTools AG
74% Downside
NANO
Nanobiotix SA
252% Upside
NBIX
Neurocrine Biosciences Inc
32% Upside
ASND
Ascendis Pharma A/S
54% Upside

Revenue
Forecast

Revenue Estimate
Molecular Partners AG

For the last 8 years the compound annual growth rate for Molecular Partners AG's revenue is -16%. The projected CAGR for the next 3 years is 42%.

-16%
Past Growth
42%
Estimated Growth
Estimates Accuracy
-26%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Molecular Partners AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Net Income
Forecast

Net Income Estimate
Molecular Partners AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MOLN's stock price target?
Price Target
11.22 CHF

According to Wall Street analysts, the average 1-year price target for MOLN is 11.22 CHF with a low forecast of 7.07 CHF and a high forecast of 15.75 CHF.

What is Molecular Partners AG's Revenue forecast?
Projected CAGR
42%

For the last 8 years the compound annual growth rate for Molecular Partners AG's revenue is -16%. The projected CAGR for the next 3 years is 42%.

Back to Top